# Verification Layer & Benchmark Status

**Date**: January 27, 2025  
**Status**: ✅ Verification Layer Complete | ⚠️ Benchmark Issues Identified

---

## 🎯 EXECUTIVE SUMMARY

**Verification Layer**: ✅ **COMPLETE** - 6/6 scripts passing, 8/8 tasks complete, 100% pass rate  
**Benchmark Integration**: ⚠️ **ISSUES IDENTIFIED** - TMB/HRD/MSI not integrated, parsing bugs, drug matching issues

---

## ✅ VERIFICATION LAYER STATUS

### **Implementation Complete**

**All 8 Tasks Complete**:
1. ✅ Variant Classification Verification (`verify_variant_classification.py`)
2. ✅ Pathway Mapping Verification (`verify_pathway_mapping.py`)
3. ✅ Functional Annotation Verification (`verify_functional_annotation.py`)
4. ✅ Eligibility & IO Verification (`verify_eligibility_io.py`)
5. ✅ DNA Repair Formula Verification (integrated in pathway mapping)
6. ✅ Mechanism Vector Verification (`verify_mechanism_vector.py`)
7. ✅ Consistency Checks (`verify_consistency.py`)
8. ✅ Unified Verification Script (`verify_mbd4_analysis.py`)

**Test Results**: ✅ **100% Pass Rate** (8/8 checks passed)

### **Fixes Applied**

1. **Pathway Extraction**: Fixed nested structure access (`phases.phase4_trials.mechanism_vector.pathway_disruption`)
2. **Variant Consistency**: Fixed dict vs list handling for variants
3. **Result Aggregation**: Fixed JSON loading and pass rate calculation

### **Files Created**

- `scripts/sae/verify_variant_classification.py` (466 lines)
- `scripts/sae/verify_pathway_mapping.py` (524 lines)
- `scripts/sae/verify_functional_annotation.py` (377 lines)
- `scripts/sae/verify_eligibility_io.py` (300+ lines)
- `scripts/sae/verify_mechanism_vector.py` (250+ lines)
- `scripts/sae/verify_consistency.py` (250+ lines)
- `scripts/sae/verify_mbd4_analysis.py` (241 lines)

**Total**: ~2,400 lines of verification code

---

## ⚠️ BENCHMARK INTEGRATION ISSUES

### **Issue 1: TMB/HRD/MSI Not Integrated** (P0 - CRITICAL)

**Problem**: Benchmark scripts don't extract or pass TMB/HRD/MSI to API  
**Impact**: Missing IO boosts and PARP rescue signals → weak correlations (r=0.037-0.278)

**Required Fixes**:
1. Create `biomarker_extractor.py` utility
2. Update `api_client.py` to accept `tumor_context` parameter
3. Update benchmark scripts to extract and pass biomarkers

**Expected Impact**: Correlation should improve (r > 0.2) when sporadic gates are applied

---

### **Issue 2: PFS_STATUS Parsing Bug** (P0)

**Problem**: Classification shows "0 events AND 0 censored" (impossible)  
**Impact**: Cannot assess classification accuracy

**Required Fixes**:
1. Create `pfs_status_parser.py` utility
2. Fix `classification.py` metrics to use parser
3. Handle multiple field name formats

---

### **Issue 3: Drug Name Matching** (P1)

**Problem**: Top-1 accuracy = 0% (drug names don't match)  
**Impact**: Lower precision in top recommendations

**Required Fixes**:
1. Create `drug_normalizer.py` utility (synonyms, brand names)
2. Fix `drug_ranking.py` metrics to use normalizer

**Expected Impact**: Top-1 accuracy > 20% (from 0%)

---

### **Issue 4: Patient Selection Bias** (P1)

**Problem**: Testing with lowest mutation counts (2-18 mutations)  
**Impact**: May not represent typical patients

**Required Fixes**:
1. Add stratified sampling functions
2. Add `--mode` argument (random/stratified/validation)
3. Add bias comparison reporting

---

### **Issue 5: Data Quality Validation** (P1)

**Problem**: Need to validate dataset before running  
**Impact**: Prevents bugs from recurring

**Required Fixes**:
1. Create `data_quality.py` checker
2. Validate PFS_STATUS field format
3. Report TMB/HRD/MSI field availability

---

## 📊 VALIDATION REALITY CHECK

### **What We CAN Validate**

**For Ovarian Cancer**:
- ✅ **MAPK pathway resistance**: 2.7x relative risk (NF1 mutations)
- ✅ **Mechanism-based trial matching**: Algorithm works correctly
- ✅ **Pathway mapping**: Gene→pathway assignments (KEGG, Reactome)
- ✅ **Variant classification**: Pathogenic vs. benign (ClinVar, COSMIC)
- ✅ **Formula correctness**: DNA repair capacity, mechanism vectors

### **What We CANNOT Validate (Without Better Data)**

**For Ovarian Cancer**:
- ❌ **DDR/BRCA response prediction**: No signal (84% sensitive, too biased)
- ❌ **Platinum response prediction**: All models fail (AUROC ~0.42-0.52)
- ❌ **Drug efficacy scores**: Require clinical trial validation
- ❌ **Mechanism fit ranking**: Require trial enrollment outcomes

### **Cohort Bias Issue**

**TCGA-OV Cohort** (469 patients):
- Sensitive: 396 (84.4%)
- Resistant: 31 (6.6%)
- Refractory: 42 (9.0%)

**Impact**: Heavily biased toward responders → hard to detect response predictors, easy to detect resistance predictors

---

## 🔧 REQUIRED FIXES (Priority Order)

### **P0: Critical Fixes** (Week 1)

1. **TMB/HRD/MSI Integration**
   - Create `biomarker_extractor.py`
   - Update `api_client.py` with `tumor_context` support
   - Update benchmark scripts
   - **Time**: 5-6 hours

2. **PFS_STATUS Parser**
   - Create `pfs_status_parser.py`
   - Fix `classification.py` metrics
   - **Time**: 3 hours

**Expected Impact**: Correlation improves (r > 0.2), classification metrics work

---

### **P1: Ranking Precision** (Week 2)

1. **Drug Name Normalizer**
   - Create `drug_normalizer.py`
   - Fix `drug_ranking.py` metrics
   - **Time**: 3 hours

2. **Data Quality Checker**
   - Create `data_quality.py`
   - **Time**: 1 hour

**Expected Impact**: Top-1 accuracy > 20% (from 0%)

---

### **P1: Validation Set Bias** (Week 3)

1. **Stratified Sampling**
   - Add sampling functions to `patient_selection.py`
   - Add `--mode` argument to benchmark scripts
   - **Time**: 3-4 hours

**Expected Impact**: More representative sample, better correlation estimates

---

## 📁 FILES TO CREATE/MODIFY

### **New Utilities** (5 files)
1. `scripts/benchmark/benchmark_common/utils/biomarker_extractor.py`
2. `scripts/benchmark/benchmark_common/utils/pfs_status_parser.py`
3. `scripts/benchmark/benchmark_common/utils/drug_normalizer.py`
4. `scripts/benchmark/benchmark_common/data_quality.py`
5. `scripts/benchmark/validate_biomarker_integration.py` (optional)

### **Files to Update** (4 files)
1. `scripts/benchmark/benchmark_common/api_client.py` - Add `tumor_context` parameter
2. `scripts/benchmark/benchmark_small_test.py` - Add biomarker extraction, `--mode` argument
3. `scripts/benchmark/benchmark_common/metrics/classification.py` - Use PFS parser
4. `scripts/benchmark/benchmark_common/metrics/drug_ranking.py` - Use drug normalizer

---

## 🎯 SUCCESS CRITERIA

### **Verification Layer** ✅
- ✅ All 8 tasks complete
- ✅ 6/6 scripts passing
- ✅ 100% pass rate on unified test

### **Benchmark Integration** (Target)
- ✅ TMB/HRD/MSI extracted and passed to API (100% of patients where available)
- ✅ Sporadic gates applied (IO boost, PARP rescue visible)
- ✅ Correlation improves: r > 0.2 (from r=0.037-0.278)
- ✅ Classification metrics work (events/censored detected)
- ✅ Top-1 accuracy > 20% (from 0%)

---

## 📊 CURRENT STATUS

**Verification Layer**: ✅ **COMPLETE** - Ready for production use  
**Benchmark Integration**: ⚠️ **IN PROGRESS** - Issues identified, fixes required  
**MBD4+TP53 Analysis**: ✅ Scripts ready - Requires backend running

---

**Last Updated**: January 27, 2025  
**Next Step**: Implement P0 benchmark fixes (TMB/HRD/MSI integration, PFS parser)












